Ian MacLachlan
Corporate Officer/Principal en New York Academy of Sciences .
Perfil
Ian MacLachlan was the founder of Protiva Biotherapeutics, Inc. which was founded in 2000, where he held the title of Chief Scientific Officer from 2000 to 2008.
He also currently holds positions as a Member at the New York Academy of Sciences, the American Society of Gene Therapy, and the Oligonucleotide Therapeutics Society, Inc. Dr. MacLachlan's former position was as the Chief Technical Officer & Executive VP at Arbutus Biopharma Corp.
from 2014 to 2014.
Dr. MacLachlan received his undergraduate and doctorate degrees from the University of Alberta.
Cargos activos de Ian MacLachlan
| Empresas | Cargo | Inicio |
|---|---|---|
New York Academy of Sciences
 New York Academy of Sciences Miscellaneous Commercial ServicesCommercial Services New York Academy of Sciences is an independent, not-for-profit organization, which engages in the advancement of scientific research, education, and policy. The company was founded in 1817 and is headquartered in New York, NY. | Corporate Officer/Principal | - |
Oligonucleotide Therapeutics Society, Inc.
 Oligonucleotide Therapeutics Society, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Beckman Research Institute of The City of Hope, Oligonucleotide Therapeutics Society, Inc. is a society that envisions a new era of oligonucleotide drugs that would change the landscape of therapeutic modalities. The company is based in San Diego, CA. Over 100 treatments are in development for common conditions, including cancer and Alzheimer’s disease, as well as rare diseases. The society offers various awards to support the accomplishments of students, postdocs, and young investigators. | Corporate Officer/Principal | - |
| American Society of Gene Therapy | Corporate Officer/Principal | - |
Antiguos cargos conocidos de Ian MacLachlan.
| Empresas | Cargo | Fin |
|---|---|---|
| ARBUTUS BIOPHARMA CORPORATION | Director Técnico/Científico/I+D | 31/12/2014 |
Protiva Biotherapeutics, Inc.
 Protiva Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Protiva Biotherapeutics, Inc. develops pharmaceutical products for human diseases. The firm offers drugs for cancer, influenza (including H5N1), Ebola, inflammatory diseases and other chronic viral infections. The company was founded in September, 2000 and is headquartered in Seattle, WA. | Fundador | 02/12/2008 |
Formación de Ian MacLachlan.
| University of Alberta | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| ARBUTUS BIOPHARMA CORPORATION | Health Technology |
| Empresas privadas | 4 |
|---|---|
Protiva Biotherapeutics, Inc.
Protiva Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Protiva Biotherapeutics, Inc. develops pharmaceutical products for human diseases. The firm offers drugs for cancer, influenza (including H5N1), Ebola, inflammatory diseases and other chronic viral infections. The company was founded in September, 2000 and is headquartered in Seattle, WA. | Health Technology |
New York Academy of Sciences
New York Academy of Sciences Miscellaneous Commercial ServicesCommercial Services New York Academy of Sciences is an independent, not-for-profit organization, which engages in the advancement of scientific research, education, and policy. The company was founded in 1817 and is headquartered in New York, NY. | Commercial Services |
Oligonucleotide Therapeutics Society, Inc.
Oligonucleotide Therapeutics Society, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Beckman Research Institute of The City of Hope, Oligonucleotide Therapeutics Society, Inc. is a society that envisions a new era of oligonucleotide drugs that would change the landscape of therapeutic modalities. The company is based in San Diego, CA. Over 100 treatments are in development for common conditions, including cancer and Alzheimer’s disease, as well as rare diseases. The society offers various awards to support the accomplishments of students, postdocs, and young investigators. | Commercial Services |
| American Society of Gene Therapy |
- Bolsa de valores
- Insiders
- Ian MacLachlan
